Chromogenic detection of telomere lengths in situ aids the identification of precancerous lesions in the prostate.

Onur ErtuncErica SmearmanQizhi ZhengJessica L HicksJacqueline A Brosnan-CashmanTracy JonesCarolina Gomes-AlexandreLevent TrabzonluAlan K MeekerAngelo M De MarzoChristopher M Heaphy

Published in: The Prostate (2023)

In summary, with fewer restrictions on the types of tissues that can be tested, and increased histologic information provided, the advantages presented by this novel chromogenic assay should extend the applicability of tissue-based telomere length assessment in research and clinical settings.

Keyphrases

prostate cancer
high throughput
gene expression
loop mediated isothermal amplification
antiretroviral therapy
benign prostatic hyperplasia
label free
health information
bioinformatics analysis
social media
single cell
quantum dots
clinical evaluation